Arxis, Inc. Class A Common Stock (ARXS)vsRTX Corporation (RTX)
ARXS
Arxis, Inc. Class A Common Stock
$52.45
+0.90%
INDUSTRIALS · Cap: $22.59B
RTX
RTX Corporation
$197.68
-0.22%
INDUSTRIALS · Cap: $266.42B
Smart Verdict
WallStSmart Research — data-driven comparison
RTX Corporation generates 5182% more annual revenue ($93.50B vs $1.77B). RTX leads profitability with a 8.3% profit margin vs 7.2%. RTX trades at a lower P/E of 34.9x. RTX earns a higher WallStSmart Score of 59/100 (C).
ARXS
Avoid35
out of 100
Grade: F
RTX
Buy59
out of 100
Grade: C
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 25.0% year-over-year
Mega-cap, among the largest globally
Earnings expanding 28.7% YoY
Generating 3.6B in free cash flow
Areas to Watch
0.0% earnings growth
ROE of 0.3% — below average capital efficiency
7.2% margin — thin
Premium valuation, high expectations priced in
Expensive relative to growth rate
Premium valuation, high expectations priced in
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : ARXS
The strongest argument for ARXS centers on Revenue Growth. Revenue growth of 25.0% demonstrates continued momentum.
Bull Case : RTX
The strongest argument for RTX centers on Market Cap, EPS Growth, Free Cash Flow. Revenue growth of 14.5% demonstrates continued momentum.
Bear Case : ARXS
The primary concerns for ARXS are EPS Growth, Return on Equity, Profit Margin. A P/E of 749.0x leaves little room for execution misses.
Bear Case : RTX
The primary concerns for RTX are PEG Ratio, P/E Ratio, Altman Z-Score.
Key Dynamics to Monitor
ARXS profiles as a growth stock while RTX is a value play — different risk/reward profiles.
ARXS is growing revenue faster at 25.0% — sustainability is the question.
RTX generates stronger free cash flow (3.6B), providing more financial flexibility.
Monitor AEROSPACE & DEFENSE industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RTX scores higher overall (59/100 vs 35/100) and 14.5% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Arxis, Inc. Class A Common Stock
INDUSTRIALS · AEROSPACE & DEFENSE · USA
Arxis, Inc. (ARXS) is a dynamic biotechnology company focused on developing cutting-edge therapeutics for complex diseases, leveraging a robust research and development framework. With a diverse drug pipeline targeting both rare and widespread conditions, Arxis emphasizes strategic partnerships and comprehensive clinical initiatives to drive innovation and improve patient outcomes. As it progresses through critical clinical trial phases, the company is well-positioned for substantial growth and value creation, making it an attractive proposition for institutional investors in the fast-evolving biotech sector.
RTX Corporation
INDUSTRIALS · AEROSPACE & DEFENSE · USA
Raytheon Technologies Corporation is an American multinational aerospace and defense conglomerate headquartered in Waltham, Massachusetts. It is one of the largest aerospace, intelligence services providers, and defense manufacturers in the world by revenue and market capitalization. Raytheon Technologies (RTX) researches, develops, and manufactures advanced technology products in the aerospace and defense industry, including aircraft engines, avionics, aerostructures, cybersecurity, guided missiles, air defense systems, satellites, and drones.
Visit Website →Compare with Other AEROSPACE & DEFENSE Stocks
Want to dig deeper into these stocks?